Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cullinan Therapeutics Inc (CGEM)

Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cullinan Therapeutics Inc ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 USA

www.cullinanoncology.com Employees: 85 P: 617-410-4650

Description:

Cullinan Therapeutics Inc. is a biopharmaceutical company focused on developing modality-agnostic targeted therapies. The company's product pipeline consists CLN-978. Cullinan Therapeutics Inc., formerly known as Cullinan Oncology Inc., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 919,420
Enterprise Value, $K 820,990
Shares Outstanding, K 58,228
Annual Sales, $ 0 K
Annual Net Income, $ -153,160 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -40,560 K
EBIT, $ -187,370 K
EBITDA, $ -187,060 K
60-Month Beta -0.12
% of Insider Shareholders 6.07%
% of Institutional Shareholders 86.31%
Float, K 54,694
% Float 93.93%
Short Volume Ratio 0.81

Growth:

1-Year Return 61.22%
3-Year Return -21.42%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.69 on 11/07/24
Next Earnings Date 11/13/24
Earnings Per Share ttm -2.84
EPS Growth vs. Prev Qtr 8.00%
EPS Growth vs. Prev Year 24.18%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CGEM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -26.54%
Return-on-Assets % -25.31%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.48
Book Value/Share 10.83
Interest Coverage -2.94
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar